<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">ANG</journal-id>
<journal-id journal-id-type="hwp">spang</journal-id>
<journal-id journal-id-type="nlm-ta">Angiology</journal-id>
<journal-title>Angiology</journal-title>
<issn pub-type="ppub">0003-3197</issn>
<issn pub-type="epub">1940-1574</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0003319711436247</article-id>
<article-id pub-id-type="publisher-id">10.1177_0003319711436247</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Coronary Heart Disease</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Relation Between Mean Platelet Volume and Severity of Atherosclerosis in Patients With Acute Coronary Syndromes</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Murat</surname>
<given-names>Sani Namik</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-0003319711436247">1</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Duran</surname>
<given-names>Mustafa</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff2-0003319711436247">2</xref>
<xref ref-type="corresp" rid="corresp1-0003319711436247"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kalay</surname>
<given-names>Nihat</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff3-0003319711436247">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gunebakmaz</surname>
<given-names>Ozgur</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff4-0003319711436247">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Akpek</surname>
<given-names>Mahmut</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff3-0003319711436247">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Doger</surname>
<given-names>Cihan</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-0003319711436247">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Elcik</surname>
<given-names>Deniz</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff3-0003319711436247">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ocak</surname>
<given-names>Ayse</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff3-0003319711436247">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Vatankulu</surname>
<given-names>Mehmet Akif</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff5-0003319711436247">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Turfan</surname>
<given-names>Murat</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff5-0003319711436247">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kasapkara</surname>
<given-names>Haci Ahmet</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff6-0003319711436247">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Akin</surname>
<given-names>Fatih</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff2-0003319711436247">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sahin</surname>
<given-names>Musa</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff7-0003319711436247">7</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kaya</surname>
<given-names>Mehmet Gungor</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff3-0003319711436247">3</xref>
</contrib>
</contrib-group>
<aff id="aff1-0003319711436247"><label>1</label>Etlik Ihtisas Research and Education Hospital, Ankara , Turkey</aff>
<aff id="aff2-0003319711436247"><label>2</label>Kayseri Research and Education Hospital, Kayseri, Turkey</aff>
<aff id="aff3-0003319711436247"><label>3</label>Faculty of Medicine, Erciyes University, Kayseri, Turkey</aff>
<aff id="aff4-0003319711436247"><label>4</label>Kastamonu City Hospital, Kastamonu, Turkey</aff>
<aff id="aff5-0003319711436247"><label>5</label>Faculty of Medicine, Bezmialem University, Istanbul, Turkey</aff>
<aff id="aff6-0003319711436247"><label>6</label>Atatürk Research and Education Hospital, Ankara , Turkey</aff>
<aff id="aff7-0003319711436247"><label>7</label>Faculty of Medicine, Yuzuncuyil University, Van, Turkey</aff>
<author-notes>
<corresp id="corresp1-0003319711436247">Mustafa Duran, Kayseri Research and Education Hospital, Hastaneler Caddesi, Kayseri, Turkey Email: <email>mduran2@gmail.com</email>
</corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>2</month>
<year>2013</year>
</pub-date>
<volume>64</volume>
<issue>2</issue>
<fpage>131</fpage>
<lpage>136</lpage>
<permissions>
<copyright-statement>© The Author(s) 2013</copyright-statement>
<copyright-year>2013</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract>
<p>Platelets play a central role in the pathophysiology of coronary artery disease (CAD). Increased mean platelet volume (MPV) is an indicator of platelet function and associated with poor clinical outcome in patients with acute coronary syndrome (ACS). We evaluated the relationship between MPV and severity of CAD in patients with ACS. A total of 395 patients with ACS were included. Severity of CAD was assessed with the Gensini and Syntax scores. High levels of MPV were associated with the Gensini and Syntax scores, number of diseased vessels (&gt;50%), number of critical lesions (&gt;50% and &gt;70%), and noncritical lesions. After multivariate analysis, high levels of MPV were independent predictors of multivessel CAD together with age. In patients with ACS, high MPV levels were associated with severity of CAD. It is possible that MPV can be a helpful marker in patients with CAD for the severity of coronary atherosclerosis.</p>
</abstract>
<kwd-group>
<kwd>mean platelet volume</kwd>
<kwd>acute coronary syndrome</kwd>
<kwd>Gensini score</kwd>
<kwd>Syntax score</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section1-0003319711436247">
<title>Introduction</title>
<p>Platelets play a central role in the pathophysiology of coronary artery disease (CAD). Large platelets are more active and have higher thrombotic potential.<sup>
<xref ref-type="bibr" rid="bibr1-0003319711436247">1</xref>
</sup> Increased platelet activity is associated with atherosclerotic disease, including CAD.<sup>
<xref ref-type="bibr" rid="bibr2-0003319711436247">2</xref>
</sup> Mean platelet volume (MPV) is a potentially useful marker of platelet activity. Mean platelet volume is associated with impaired angiographic reperfusion and poor clinical outcome in patients with acute coronary syndrome (ACS).<sup>
<xref ref-type="bibr" rid="bibr3-0003319711436247">3</xref>
<xref ref-type="bibr" rid="bibr4-0003319711436247"/>–<xref ref-type="bibr" rid="bibr5-0003319711436247">5</xref>
</sup>
</p>
<p>Severity of coronary atherosclerosis is closely associated with cardiovascular prognosis in patients with ACS.<sup>
<xref ref-type="bibr" rid="bibr6-0003319711436247">6</xref>
</sup> Therefore, prediction and diagnosis of severity of atherosclerosis is clinically relevant.</p>
<p>The aim of the current study was to evaluate the relationship between MPV and severity of CAD in ACS.</p>
</sec>
<sec id="section7-0003319711436247" sec-type="methods">
<title>Methods</title>
<sec id="section2-0003319711436247">
<title>Patients</title>
<p>A total of 520 consecutive patients with ACS undergoing coronary angiography were prospectively enrolled in the study. Patients with a history of prior myocardial infarction (MI), cerebrovascular event, peripheral arterial disease, percutaneous coronary intervention, coronary bypass surgery, and treatment with aspirin/clopidogrel/warfarin/unfractionated heparin and low-molecular-weight heparin were excluded. Finally, 395 patients were eligible to participate in the study. A high MPV was defined as a value ≥10.3 fl,<sup>
<xref ref-type="bibr" rid="bibr5-0003319711436247">5</xref>,<xref ref-type="bibr" rid="bibr7-0003319711436247">7</xref>
</sup> and the patients were divided into 2 groups—group 1 (low MPV) and group 2 (high MPV).</p>
<p>Three study groups were determined based on the diagnostic criteria of CAD, myocardial infarction with ST-segment elevation and non-ST-segment elevation (non-STEMI), and unstable angina pectoris (USAP). Informed consent was obtained from all patients. The study was approved by our local ethical committee. All demographic and clinical data were collected prospectively.</p>
</sec>
<sec id="section3-0003319711436247">
<title>Laboratory Analysis</title>
<p>In all cases, blood samples were drawn at admission before starting any medication. We measured MPV in a blood sample collected in dipotassium ethylenedinitrotetraacetic acid tubes. All measurements were performed 30 minutes after blood collection by automatic blood counter (A Sysmex XE-2100, Symex, Kobe, Japan). The assessment of MPV was made without clopidogrel, heparin, or abciximab on board.</p>
</sec>
<sec id="section4-0003319711436247">
<title>Coronary Angiography</title>
<p>Quantitative coronary angiography was performed by 2 experienced interventional cardiologists who had no knowledge of the patients’ clinical information. Gensini and Syntax scores were used to evaluate the severity of atherosclerosis.<sup>
<xref ref-type="bibr" rid="bibr8-0003319711436247">8</xref>,<xref ref-type="bibr" rid="bibr9-0003319711436247">9</xref>
</sup> For the Gensini score, the most severe stenosis in each of 8 coronary segments (left anterior descending artery, main diagonal branch, first septal perforator, left circumflex artery, obtuse marginal and posterolateral vessels, right coronary artery, and main descending branch) was graded from 1 to 4 (1%-49% lumen diameter reduction = 1 point, 50%-74% stenosis = 2, 75%-99% stenosis = 3, 100% occlusion = 4) to give a total score between 0 and 32. Syntax score was calculated with Syntax score calculator 2.1 (www.syntaxscore.com). The number of diseased vessels with &gt;50% luminal stenosis was scored from 1 to 3 or more diseased vessels. Coronary stenotic lesions with &gt;50% or &gt;70% luminal stenosis were defined as critical lesions and with &lt;50% luminal stenosis was defined as noncritical lesions.</p>
</sec>
<sec id="section5-0003319711436247">
<title>Statistical Analysis</title>
<p>All analyses were performed using SPSS V 16.0 for windows (SPSS, Chicago, Illinois). Quantitative variables were expressed as mean ± standard deviation (SD) for parametric variables and as median and minimum–maximum levels for nonparametric variables. Comparison of parametric values between the 2 groups was performed by means of independent samples <italic>t</italic> test. Comparisons of nonparametric values between the 2 groups were performed by Mann-Whitney <italic>U</italic> test. Categorical variables were compared by the the chi-square test. Pearson test was used to test the correlation of parametric variables, and Spearman test was used to test the nonparametric variables. Differences among the number of diseased vessel groups were tested with 1-way analysis of variance (ANOVA). Multivariate logistic regression analysis was performed to assess the effects of the variables on multivessel disease. Multivariate linear regression analysis was performed to evaluate the effects of the variables on the Gensini score and Syntax score. A 2-tailed <italic>P</italic> &lt; .05 was considered significant.</p>
</sec>
</sec>
<sec id="section6-0003319711436247">
<title>Results</title>
<p>Demographic and clinical properties of patients in groups are shown in <xref ref-type="table" rid="table1-0003319711436247">Table 1</xref>. Age, gender, smoking, diabetes, hypertension, and body mass index were similar in the 2 groups. Platelet count was significantly higher in group 1 than in group 2 (233 ± 64 × 10<sup>6</sup> vs 210 ± 51 × 10<sup>6</sup>; <italic>P</italic> = .003). Mean platelet volume was 8.3 ± 0.9 in group 1 and 10.8 ± 0.4 in group 2 (<italic>P</italic> &lt; .001). Low-density lipoprotein (LDL) cholesterol was high in group 2 (<italic>P</italic> = .042) and triglyceride was high in group 1 (<italic>P</italic> = .001). Non-STEMI ratio was significantly higher in group 2 than in group 1 (48 [51.0%] vs 96 [31.8%]; <italic>P</italic> = .001). However, STEMI ratio was higher in group 1 than in group 2 (103 [34.2%] vs 18 [19.4%]; <italic>P</italic> = .006).</p>
<table-wrap id="table1-0003319711436247" position="float">
<label>Table 1.</label>
<caption>
<p>Relation Between Mean Platelet Volume and Clinical and Laboratory Findings</p>
</caption>
<graphic alternate-form-of="table1-0003319711436247" xlink:href="10.1177_0003319711436247-table1.tif"/>
<table>
<thead>
<tr>
<th>
</th>
<th>Group 1 (n = 301)</th>
<th>Group 2 (n = 94)</th>
<th>
<italic>P</italic>
</th>
</tr>
</thead>
<tbody>
<tr>
<td>Age, years</td>
<td>59 ± 12</td>
<td>61 ± 11</td>
<td>.125</td>
</tr>
<tr>
<td>Gender, male (%)</td>
<td>228 (75.7%)</td>
<td>75 (79.7%)</td>
<td>.254</td>
</tr>
<tr>
<td>Smoking, n (%)</td>
<td>153 (50.8%)</td>
<td>51 (54.2%)</td>
<td>.322</td>
</tr>
<tr>
<td>Diabetes, n (%)</td>
<td>50 (16.6%)</td>
<td>9 (9.6%)</td>
<td>.095</td>
</tr>
<tr>
<td>Hypertension, n (%)</td>
<td>61 (20.3%)</td>
<td>13 (13.8%)</td>
<td>.163</td>
</tr>
<tr>
<td>Platelet, ×10<sup>6</sup>
</td>
<td>233 ± 64</td>
<td>210 ± 51</td>
<td>.003</td>
</tr>
<tr>
<td>Mean platelet volume, fl</td>
<td>8.3 ± 0.9</td>
<td>10.8 ± 0.4</td>
<td>&lt; .001</td>
</tr>
<tr>
<td>Systolic BP, mm Hg</td>
<td>120 (80-210)</td>
<td>110 (90-140)</td>
<td>.052</td>
</tr>
<tr>
<td>Diastolic BP, mm Hg</td>
<td>70 (50-130)</td>
<td>70 (50-100)</td>
<td>.013</td>
</tr>
<tr>
<td>BMI, kg/m<sup>2</sup>
</td>
<td>27 (22-36)</td>
<td>26.1 (20-33)</td>
<td>.114</td>
</tr>
<tr>
<td>Hemoglobin, mg/dL</td>
<td>14.1 ± 2.0</td>
<td>14.3 ± 1.8</td>
<td>.232</td>
</tr>
<tr>
<td>Glucose, mg/dL</td>
<td>107 (58-463)</td>
<td>99 (55-447)</td>
<td>.106</td>
</tr>
<tr>
<td>Creatinine, mg/dL</td>
<td>0.9 ± 0.2</td>
<td>0.9 ± 0.2</td>
<td>.812</td>
</tr>
<tr>
<td>Total cholesterol, mg/dL</td>
<td>184 ± 44</td>
<td>179 ± 36</td>
<td>.508</td>
</tr>
<tr>
<td>LDL-C, mg/dL</td>
<td>114 ± 40</td>
<td>121 ± 31</td>
<td>.042</td>
</tr>
<tr>
<td>HDL-C, mg/dL</td>
<td>35 (16-88)</td>
<td>33 (20-62)</td>
<td>.072</td>
</tr>
<tr>
<td>Triglycerides, mg/dL</td>
<td>135 (28-849)</td>
<td>108 (22-325)</td>
<td>.001</td>
</tr>
<tr>
<td>USAP, n (%)</td>
<td>102 (33.8%)</td>
<td>28 (29.7%)</td>
<td>.461</td>
</tr>
<tr>
<td>Non-STEMI, n (%)</td>
<td>96 (31.8%)</td>
<td>48 (51.0%)</td>
<td>.001</td>
</tr>
<tr>
<td>STEMI, n (%)</td>
<td>103 (34.2%)</td>
<td>18 (19.4%)</td>
<td>.006</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-0003319711436247">
<p>Abbreviations: BMI, body mass index; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; USAP, unstable angina pectoris; STEMI, ST-elevation myocardial infarction.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>The comparisons of angiographic properties of patients in the 2 groups are shown in <xref ref-type="table" rid="table2-0003319711436247">Table 2</xref>. Gensini score was higher in group 2 than in group 1 (9.5 ± 4.4 vs 7.9 ± 4.0; <italic>P</italic> = .001), and Syntax score was higher in group 2 (16.1 ± 8.4 vs 13.9 ± 9.0; <italic>P</italic> = .016). Also, the number of diseased vessels (<italic>P</italic> = .013), number of critical lesions (&gt;50% and 70%; <italic>P</italic> = .028 and <italic>P</italic> = .020, respectively), and number of noncritical lesions (<italic>P</italic> &lt; .001) were higher in group 2. However, the number of lessions with total occlusion, left main disease and presence of classification and thrombus were not significant difference in 2 groups.</p>
<table-wrap id="table2-0003319711436247" position="float">
<label>Table 2.</label>
<caption>
<p>Association of Atherosclerotic Characteristics of Patients and MPV</p>
</caption>
<graphic alternate-form-of="table2-0003319711436247" xlink:href="10.1177_0003319711436247-table2.tif"/>
<table>
<thead>
<tr>
<th>
</th>
<th>Group 1(n = 301)</th>
<th>Group 2 (n = 94)</th>
<th>
<italic>P</italic>
</th>
</tr>
</thead>
<tbody>
<tr>
<td>Gensini score</td>
<td>7.9 ± 4.0</td>
<td>9.5 ± 4.4</td>
<td>.001</td>
</tr>
<tr>
<td>Syntax score</td>
<td>13.9 ± 9.0</td>
<td>16.1 ± 8.4</td>
<td>.016</td>
</tr>
<tr>
<td>Number of diseased vessels</td>
<td>1.9 ± 0.8</td>
<td>2.2 ± 0.8</td>
<td>.013</td>
</tr>
<tr>
<td>Number of diseased vessels (&gt;50%)</td>
<td>1.8 ± 0.9</td>
<td>2.2 ± 0.9</td>
<td>.005</td>
</tr>
<tr>
<td>Number of critical lesions (&gt;50%)</td>
<td>2.4 ± 1.4</td>
<td>2.9 ± 1.6</td>
<td>.028</td>
</tr>
<tr>
<td>Number of critical lesions (&gt;70%)</td>
<td>2.0 ± 1.3</td>
<td>2.4 ± 1.4</td>
<td>.020</td>
</tr>
<tr>
<td>Number of noncritical lesions</td>
<td>0 (0-6)</td>
<td>1 (0-6)</td>
<td>&lt; .001</td>
</tr>
<tr>
<td>Totally occlusion, n (%)</td>
<td>165 (54.8%)</td>
<td>45 (47.8%)</td>
<td>.318</td>
</tr>
<tr>
<td>Left main disease, n (%)</td>
<td>6 (2%)</td>
<td>5 (5.3%)</td>
<td>.090</td>
</tr>
<tr>
<td>Classification, n (%)</td>
<td>25 (8%)</td>
<td>5 (5.3%)</td>
<td>.333</td>
</tr>
<tr>
<td>Thrombus, n (%)</td>
<td>30 (9.9%)</td>
<td>9 (9.5%)</td>
<td>.897</td>
</tr>
<tr>
<td>1 vessel, n (%)</td>
<td>118 (39.2%)</td>
<td>21 (22.4%)</td>
<td rowspan="3">.013</td>
</tr>
<tr>
<td>2 vessels, n (%)</td>
<td>80 (26.6%)</td>
<td>32 (34.0%)</td>
</tr>
<tr>
<td>3 or more vessels, n (%)</td>
<td>103 (34.2%)</td>
<td>41 (43.6%)</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>Baseline clinical characteristics of the study population according to the angiographic findings are shown in <xref ref-type="table" rid="table3-0003319711436247">Table 3</xref>. The MPV was higher in 2-vessel, 3-vessel, or more vessel disease (<xref ref-type="fig" rid="fig1-0003319711436247">Figure 1</xref>). Also age, glucose, and creatinine level were high in multivessel disease.</p>
<fig id="fig1-0003319711436247" position="float">
<label>Figure 1.</label>
<caption>
<p>Graph of relation between levels of MPV and number of diseased vessels. MPV indicates mean platelet volume.</p>
</caption>
<graphic xlink:href="10.1177_0003319711436247-fig1.tif"/>
</fig>
<table-wrap id="table3-0003319711436247" position="float">
<label>Table 3.</label>
<caption>
<p>Baseline Clinical Characteristics of the Study Population According to the Angiographic Findings</p>
</caption>
<graphic alternate-form-of="table3-0003319711436247" xlink:href="10.1177_0003319711436247-table3.tif"/>
<table>
<thead>
<tr>
<th>
</th>
<th>1 Vessel (n = 139)</th>
<th>2 Vessels (n = 112)</th>
<th>≥3 Vessels (n = 144)</th>
<th>
<italic>P</italic>
</th>
</tr>
</thead>
<tbody>
<tr>
<td>Mean platelet volume, fl</td>
<td>8.6 (6.3-11.6)</td>
<td>9.0 (6.1-12.5)</td>
<td>9.2 (6.6-12.0)</td>
<td>.002</td>
</tr>
<tr>
<td>Gensini score</td>
<td>5 (2-11)</td>
<td>7 (4-16)</td>
<td>12 (4-28)</td>
<td>&lt; .001</td>
</tr>
<tr>
<td>Syntax score</td>
<td>7 (0-22)</td>
<td>13 (3-32)</td>
<td>20 (4-46)</td>
<td>&lt; .001</td>
</tr>
<tr>
<td>Age, years</td>
<td>56 ± 12</td>
<td>59 ± 12</td>
<td>63 ± 11</td>
<td>&lt; .001</td>
</tr>
<tr>
<td>Systolic BP, mm Hg</td>
<td>117 (90-190)</td>
<td>119 (85-170)</td>
<td>119 (80-210)</td>
<td>.844</td>
</tr>
<tr>
<td>Diastolic BP, mm Hg</td>
<td>72 (50-110)</td>
<td>74 (50-100)</td>
<td>73 (50-130)</td>
<td>.821</td>
</tr>
<tr>
<td>BMI, kg/m<sup>2</sup>
</td>
<td>27.9 (22-36)</td>
<td>26.1 (21-34.6)</td>
<td>26.4 (20-33)</td>
<td>.060</td>
</tr>
<tr>
<td>Hemoglobin, mg/dL</td>
<td>14.5 (9.4-19.0)</td>
<td>14.2 (9.3-17.8)</td>
<td>13.9 (9.0-18.6)</td>
<td>.020</td>
</tr>
<tr>
<td>White blood cell, mm<sup>3</sup>
</td>
<td>10.3 (4.2-20.0)</td>
<td>10.3 (4.6-17.7)</td>
<td>10.4 (4.1-21.1)</td>
<td>.955</td>
</tr>
<tr>
<td>Glucose, mg/dL</td>
<td>109 ± 48</td>
<td>125 ± 68</td>
<td>142 ± 85</td>
<td>.001</td>
</tr>
<tr>
<td>BUN, mg/dL</td>
<td>24.2 (8-47)</td>
<td>23.1 (5-44)</td>
<td>24.6 (9-46)</td>
<td>.457</td>
</tr>
<tr>
<td>Creatinine, mg/dL</td>
<td>0.8 (0.3-1.4)</td>
<td>0.9 (0.3-1.4)</td>
<td>0.9 (0.2-1.4)</td>
<td>0.007</td>
</tr>
<tr>
<td>Total cholesterol, mg/dL</td>
<td>178 ± 39</td>
<td>187 ± 44</td>
<td>185 ± 43</td>
<td>.212</td>
</tr>
<tr>
<td>LDL-C, mg/dL</td>
<td>111 ± 37</td>
<td>119 ± 39</td>
<td>118 ± 37</td>
<td>.239</td>
</tr>
<tr>
<td>HDL-C, mg/dL</td>
<td>37 (16-88)</td>
<td>36 (20-81)</td>
<td>37 (21-79)</td>
<td>.763</td>
</tr>
<tr>
<td>Triglycerides, mg/dL</td>
<td>155 (22-849)</td>
<td>152 (41-604)</td>
<td>153 (28-675)</td>
<td>.978</td>
</tr>
<tr>
<td>Total protein, g/dL</td>
<td>7.3 ± 0.6</td>
<td>6.5 ± 0.6</td>
<td>6.6 ± 0.6</td>
<td>.267</td>
</tr>
<tr>
<td>Albumin, g/dL</td>
<td>4.0 ± 0.5</td>
<td>3.8 ± 0.4</td>
<td>3.8 ± 0.5</td>
<td>.052</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn2-0003319711436247">
<p>Abbreviations: BP, blood pressure; BMI, body mass index; BUN, blood urea nitrogen; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>A high MPV correlated with the Gensini and Syntax scores (<italic>r</italic> = .304, <italic>P</italic> &lt; .001 and <italic>r</italic> = .314, <italic>P</italic> &lt; .001, respectively; <xref ref-type="fig" rid="fig2-0003319711436247">Figure 2</xref>), number of diseased vessels (<italic>P</italic> = .005), number of critical lesions (for &gt;50% <italic>P</italic> = .028 and for &gt;70% <italic>P</italic> = .020), and noncritical lesions (<italic>P</italic> &lt; .001). Gensini score was associated with MPV (<italic>r</italic> = .304, <italic>P</italic> &lt; .001), age (<italic>r</italic> = .192, <italic>P</italic> &lt; .001), number of diseased vessel (<italic>r</italic> = .769, <italic>P</italic> &lt; .001). Syntax score was significantly correlated with MPV (<italic>r</italic> = .314, <italic>P</italic> &lt; .001), age (<italic>r</italic> = .192, <italic>P</italic> &lt; .001), hemoglobin (<italic>r</italic> = −.145, <italic>P</italic> = .010), and glucose (<italic>r</italic> = .128, <italic>P</italic> &lt; .001).</p>
<fig id="fig2-0003319711436247" position="float">
<label>Figure 2.</label>
<caption>
<p>Graph of relation between levels of MPV and Gensini and Syntax scores. MPV indicates mean platelet volume.</p>
</caption>
<graphic xlink:href="10.1177_0003319711436247-fig2.tif"/>
</fig>
<p>After multivariate analysis, high MPV levels were independent predictors of multivessel CAD (odds ratio [OR]: 1.77, 95% confidence interval [CI] 1.31-2.39; <italic>P</italic> &lt; .001) together with age (OR: 1.04, 95% CI 1.00-1.07; <italic>P</italic> = .033). Multivariate linear regression analysis demonstrated that the increased MPV level was an independent risk factor for the Syntax and Gensini scores (b = .344, <italic>P</italic> &lt; .001 and b = .311, <italic>P</italic> &lt; .001, respectively) together with age (b = .212, <italic>P</italic> = .013 and b = .208, <italic>P</italic> = .009, respectively; <xref ref-type="table" rid="table4-0003319711436247">Table 4</xref>).</p>
<table-wrap id="table4-0003319711436247" position="float">
<label>Table 4.</label>
<caption>
<p>Multivariate Analysis of Determinants of Syntax Score</p>
</caption>
<graphic alternate-form-of="table4-0003319711436247" xlink:href="10.1177_0003319711436247-table4.tif"/>
<table>
<thead>
<tr>
<th>
</th>
<th colspan="2">Unstandardized Coefficients</th>
<th>Standardized Coefficients</th>
<th>
</th>
<th>
</th>
</tr>
<tr>
<th>Independent Variables</th>
<th>B</th>
<th>SE</th>
<th>β</th>
<th>
<italic>t</italic>
</th>
<th>
<italic>P</italic>
</th>
</tr>
</thead>
<tbody>
<tr>
<td>MPV</td>
<td align="center">2026</td>
<td>0.508</td>
<td>0.344</td>
<td>3.988</td>
<td>&lt;.001</td>
</tr>
<tr>
<td>Age</td>
<td>0.152</td>
<td>0.061</td>
<td>0.212</td>
<td>2.503</td>
<td>.013</td>
</tr>
<tr>
<td>Gender</td>
<td>2.245</td>
<td>2.083</td>
<td>0.092</td>
<td>1.078</td>
<td>.283</td>
</tr>
<tr>
<td>Hypertension</td>
<td>−0.220</td>
<td>3.145</td>
<td>−0.007</td>
<td>−0.070</td>
<td>.944</td>
</tr>
<tr>
<td>Diabetes</td>
<td>4.530</td>
<td>3.437</td>
<td>0.116</td>
<td>1.318</td>
<td>.190</td>
</tr>
<tr>
<td>Smoking</td>
<td>0.505</td>
<td>1.700</td>
<td>0.027</td>
<td>0.297</td>
<td>.767</td>
</tr>
<tr>
<td>BUN</td>
<td>0.076</td>
<td>0.085</td>
<td>0.076</td>
<td>0.892</td>
<td>.374</td>
</tr>
<tr>
<td>Creatinine</td>
<td>−0.669</td>
<td>3.336</td>
<td>−0.016</td>
<td>−0.201</td>
<td>.841</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn3-0003319711436247">
<p>Abbreviations: MPV, mean platelet volume; BUN, blood urea nitrogen.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="section70-0003319711436247">
<title>Discussion</title>
<p>To our knowledge this is the first study that showed a positive relationship between high levels of MPV and severity of CAD in patients with ACS.</p>
<p>Platelets play a key role in the pathogenesis, morbidity, and mortality in ACS.<sup>
<xref ref-type="bibr" rid="bibr2-0003319711436247">2</xref>,<xref ref-type="bibr" rid="bibr5-0003319711436247">5</xref>,<xref ref-type="bibr" rid="bibr10-0003319711436247">10</xref>
</sup> Elevated MPV has been proposed as a cardiovascular risk factor and has been recognized as an independent risk factor for myocardial infarction and adverse cardiovascular events such as recurrent ischemia or death.<sup>
<xref ref-type="bibr" rid="bibr11-0003319711436247">11</xref>
<xref ref-type="bibr" rid="bibr12-0003319711436247"/>–<xref ref-type="bibr" rid="bibr13-0003319711436247">13</xref>
</sup> Several studies showed an association between MPV and CAD, stable angina pectoris, unstable angina pectoris, and acute MI.<sup>
<xref ref-type="bibr" rid="bibr3-0003319711436247">3</xref>,<xref ref-type="bibr" rid="bibr5-0003319711436247">5</xref>,<xref ref-type="bibr" rid="bibr11-0003319711436247">11</xref>
<xref ref-type="bibr" rid="bibr12-0003319711436247"/>
<xref ref-type="bibr" rid="bibr13-0003319711436247"/>–<xref ref-type="bibr" rid="bibr14-0003319711436247">14</xref>
</sup> Several reports have also reported that MPV was associated with impaired myocardial perfusion and restenosis after primary coronary intervention.<sup>
<xref ref-type="bibr" rid="bibr5-0003319711436247">5</xref>,<xref ref-type="bibr" rid="bibr13-0003319711436247">13</xref>,<xref ref-type="bibr" rid="bibr15-0003319711436247">15</xref>
</sup>
</p>
<p>Platelets with high MPV are metabolically and enzymatically more active and secrete more mediators.<sup>
<xref ref-type="bibr" rid="bibr16-0003319711436247">16</xref>,<xref ref-type="bibr" rid="bibr17-0003319711436247">17</xref>
</sup> These mediators can contribute to inflammation and atherogenesis and may explain an association between MPV and severity of coronary atherosclerosis.<sup>
<xref ref-type="bibr" rid="bibr18-0003319711436247">18</xref>
</sup> Progression of atherosclerotic lesion was associated with chronic inflammation which was induced by platelets with chemotactic proteins, adhesion molecules, growth factors, inflammatory, and mitogenic factors.<sup>
<xref ref-type="bibr" rid="bibr17-0003319711436247">17</xref>
</sup> Active platelets stimulate smooth muscle cell, and platelet-derived CD40 ligand, platelet factor 4 (PF4), and growth factors have been found in human atherosclerotic lesions.<sup>
<xref ref-type="bibr" rid="bibr11-0003319711436247">11</xref>,<xref ref-type="bibr" rid="bibr17-0003319711436247">17</xref>,<xref ref-type="bibr" rid="bibr19-0003319711436247">19</xref>
</sup> In our study, patients with high MPV had high Gensini and Syntax scores and had more critical lesions. Therefore, an elevated MPV may indicate that patients with ACS had severe CAD and had a higher risk of acute coronary events due to increased platelet activation. So, high MPV may be useful for predicting high-risk patients.</p>
<p>Our study supports the hypothesis that platelet size may play a role in the severity of CAD. Although the physiopathogenesis of association between elevated MPV and severity of CAD is not completely understood, multiple mechanisms may be involved. The association between high MPV and severity of CAD could be explained by the increased number of both platelet leukocyte and platelet–platelet aggregation in coronary arterioles to cause microvascular injury. Chemotactic and mitogenic factors and CD40 ligands, which are expressed by activated platelets, may contribute to the extent and severity of coronary atherosclerosis. Perhaps, the extent and severity of CAD may cause increasing production of platelets with high MPV, and these larger platelets may aggregates to form plaques and contribute to the initiation of ACS.</p>
<p>Previous studies reported different results regarding the relation between MPV and severity of atherosclerosis. De Luca et al measured MPV in 1411 consecutive patients undergoing coronary angiography and showed that MPV is not related to the extent of CAD.<sup>
<xref ref-type="bibr" rid="bibr20-0003319711436247">20</xref>
</sup> Tavil et al measured MPV in 205 consecutive patients with metabolic syndrome who underwent coronary angiography and did not observe any difference in MPV among patients with or without significant CAD (patients with &gt;50% stenosis).<sup>
<xref ref-type="bibr" rid="bibr21-0003319711436247">21</xref>
</sup> Ihara et al reported that MPV showed lower values in the angiographically positive patients than angiographically negative patients.<sup>
<xref ref-type="bibr" rid="bibr22-0003319711436247">22</xref>
</sup> Our study showed for the first time a positive association between MPV and severity of CAD by Gensini and Syntax scores. Studies mentioned above did not use Gensini or Syntax scores and only one of them used extent of CAD.</p>
<p>Investigators showed that platelet volume was positively associated with increased megakaryocyte ploidy and negatively associated with number of megakaryocyte.<sup>
<xref ref-type="bibr" rid="bibr5-0003319711436247">5</xref>,<xref ref-type="bibr" rid="bibr23-0003319711436247">23</xref>
</sup> Furthermore, several studies demonstrated a significant association between MPV and cardiovascular events, even after adjusting for platelet count.<sup>
<xref ref-type="bibr" rid="bibr5-0003319711436247">5</xref>,<xref ref-type="bibr" rid="bibr11-0003319711436247">11</xref>
</sup> In accordance with previous studies, we observed that MPV was inversely correlated with the total platelet count (<italic>P</italic> = .003). A similar relationship was also observed by others.<sup>
<xref ref-type="bibr" rid="bibr24-0003319711436247">24</xref>
</sup>
</p>
<p>Previous reports showed that there is a close relationship between MPV and other prognostic factors, such as smoking, diabetes, obesity, hypertension, and hypercholesterolemia.<sup>
<xref ref-type="bibr" rid="bibr25-0003319711436247">25</xref>
<xref ref-type="bibr" rid="bibr26-0003319711436247"/>
<xref ref-type="bibr" rid="bibr27-0003319711436247"/>–<xref ref-type="bibr" rid="bibr28-0003319711436247">28</xref>
</sup> But we do not have clear information about an association between MPV and known ischemic heart disease risk factors, so an elevated MPV may contribute to adverse events through a novel mechanism. We did not find any association between MPV and smoking, diabetes, hypertension, or gender. We observed that advanced age and severity of CAD were significantly associated with larger platelets.</p>
<p>Finally, different methods can be used to assess platelet activation (eg, flow cytometry, optical aggregometry, platelet reactivity tests, or platelet aggregate ratio).<sup>
<xref ref-type="bibr" rid="bibr29-0003319711436247">29</xref>
</sup> All tests have limitations such as complex preanalytic factors, reduced specificity, and poor reproducibility. However, MPV is a marker, not requiring advanced or expensive technology.</p>
</sec>
<sec id="section8-0003319711436247">
<title>Conclusions</title>
<p>High MPV seems to be an independent risk factor for CAD and correlated with the severity of the coronary atherosclerosis. This is a simple, reliable, and economical method that indicates platelet activation and predicts the risk of ACS and coronary atherosclerosis. We suggest that MPV can be added to the conventional risk factors for CAD.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="conflict" id="fn1-0003319711436247">
<label>Declaration of Conflicting Interests</label>
<p>The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</p>
</fn>
<fn fn-type="financial-disclosure" id="fn2-0003319711436247">
<label>Funding</label>
<p>The authors received no financial support for the research, authorship, and/or publication of this article.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-0003319711436247">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Corash</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Tau</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Gralnick</surname>
<given-names>HR</given-names>
</name>
</person-group>. <article-title>Heterogeneity of human whole blood platelet subpopulations. I. Relationship between buoyant density, cell volume, and ultrastructure</article-title>. <source>Blood</source>. <year>1977</year>;<volume>49</volume>(<issue>1</issue>):<fpage>71</fpage>–<lpage>87</lpage>.</citation>
</ref>
<ref id="bibr2-0003319711436247">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Davi</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Patrono</surname>
<given-names>C</given-names>
</name>
</person-group>. <article-title>Platelet activation and atherothrombosis</article-title>. <source>N Engl Med</source>. <year>2007</year>;<volume>357</volume>(<issue>24</issue>):<fpage>2482</fpage>–<lpage>2494</lpage>.</citation>
</ref>
<ref id="bibr3-0003319711436247">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pizzulli</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>JF</given-names>
</name>
<name>
<surname>Luderitz</surname>
<given-names>B</given-names>
</name>
</person-group>. <article-title>Changes in platelet size and count in unstable angina compared to stable angina or non-cardiac chest pain</article-title>. <source>Eur Heart J</source>. <year>1998</year>;<volume>19</volume>(<issue>1</issue>):<fpage>80</fpage>–<lpage>84</lpage>.</citation>
</ref>
<ref id="bibr4-0003319711436247">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jagroop</surname>
<given-names>IA</given-names>
</name>
<name>
<surname>Mikhailidis</surname>
<given-names>DP</given-names>
</name>
</person-group>. <article-title>Mean platelet volume is an independent risk factor for myocardial infarction but not for coronary artery disease</article-title>. <source>Br J Haematol</source>. <year>2003</year>;<volume>120</volume>(<issue>1</issue>):<fpage>169</fpage>–<lpage>170</lpage>.</citation>
</ref>
<ref id="bibr5-0003319711436247">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huczek</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Kochman</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Filipak</surname>
<given-names>KJ</given-names>
</name>
<etal/>
</person-group>. <article-title>Mean platelet volume on admission predicts impaired reperfusion and long-term mortality in acute myocardial infarction treated with primary percutaneous coronary intervention</article-title>. <source>J Am Coll Cardiol</source>. <year>2005</year>;<volume>46</volume>(<issue>2</issue>):<fpage>284</fpage>–<lpage>290</lpage>.</citation>
</ref>
<ref id="bibr6-0003319711436247">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Lan</surname>
<given-names>XB</given-names>
</name>
<name>
<surname>Yin</surname>
<given-names>YH</given-names>
</name>
</person-group>. <article-title>Coronary score adds prognostic information for patients with acute coronary syntrome</article-title>. <source>Circ J</source>. <year>2010</year>;<volume>74</volume>(<issue>3</issue>):<fpage>490</fpage>–<lpage>495</lpage>.</citation>
</ref>
<ref id="bibr7-0003319711436247">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Burr</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Holliday</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Fehily</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Whitehead</surname>
<given-names>PJ</given-names>
</name>
</person-group>. <article-title>Haematological prognostic indices after myocardial infarction: evidence from the diet and reinfarction trial (DART)</article-title>. <source>Eur Heart J</source>. <year>1992</year>;<volume>13</volume>(<issue>2</issue>):<fpage>166</fpage>–<lpage>170</lpage>.</citation>
</ref>
<ref id="bibr8-0003319711436247">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gensini</surname>
<given-names>GG</given-names>
</name>
</person-group>. <article-title>A more meaningful scoring system for determining the severity of coronary heart disease</article-title>. <source>Am J Cardiol</source>. <year>1983</year>;<volume>51</volume>(<issue>3</issue>):<fpage>606</fpage>–<lpage>607</lpage>.</citation>
</ref>
<ref id="bibr9-0003319711436247">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Serruys</surname>
<given-names>PW</given-names>
</name>
<name>
<surname>Onuma</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Garg</surname>
<given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>Assessment of the SYNTAX score in the Syntax study</article-title>. <source>EuroIntervention</source>. <year>2009</year>;<volume>5</volume>(<issue>1</issue>):<fpage>50</fpage>–<lpage>56</lpage>.</citation>
</ref>
<ref id="bibr10-0003319711436247">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mikhailidis</surname>
<given-names>DP</given-names>
</name>
<name>
<surname>Barradas</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Mier</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Platelet function in patients admitted with a diagnosis of myocardial infarction</article-title>. <source>Angiology</source>. <year>1987</year>;<volume>38</volume>(<issue>1 pt 1</issue>):<fpage>36</fpage>–<lpage>45</lpage>.</citation>
</ref>
<ref id="bibr11-0003319711436247">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yilmaz</surname>
<given-names>MB</given-names>
</name>
<name>
<surname>Cihan</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Guray</surname>
<given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>Role of mean platelet volume in triagging acute coronary syndromes</article-title>. <source>J Thromb Thrombolysis</source>. <year>2008</year>;<volume>26</volume>(<issue>1</issue>):<fpage>49</fpage>–<lpage>54</lpage>.</citation>
</ref>
<ref id="bibr12-0003319711436247">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Endler</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Klimesch</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Sunder-Plassmann</surname>
<given-names>H</given-names>
</name>
<etal/>
</person-group>. <article-title>Mean platelet volume is an independent risk factor for myocardial infarction but not for coronary artery disease</article-title>. <source>Br J Haematol</source>. <year>2002</year>;<volume>117</volume>(<issue>2</issue>):<fpage>399</fpage>–<lpage>404</lpage>.</citation>
</ref>
<ref id="bibr13-0003319711436247">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chu</surname>
<given-names>SG</given-names>
</name>
<name>
<surname>Becker</surname>
<given-names>RC</given-names>
</name>
<name>
<surname>Berger</surname>
<given-names>PB</given-names>
</name>
<etal/>
</person-group>. <article-title>Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysis</article-title>. <source>J Thromb Haemost</source>. <year>2010</year>;<volume>8</volume>(<issue>1</issue>):<fpage>148</fpage>–<lpage>156</lpage>.</citation>
</ref>
<ref id="bibr14-0003319711436247">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Avramakis</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Papadimitraki</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Papakonstandinou</surname>
<given-names>D</given-names>
</name>
<etal/>
</person-group>. <article-title>Platelets and white blood cell subpopulations among patients with myocardial infarction and unstable angina</article-title>. <source>Platelets</source>. <year>2007</year>;<volume>18</volume>(<issue>1</issue>):<fpage>16</fpage>–<lpage>23</lpage>.</citation>
</ref>
<ref id="bibr15-0003319711436247">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maden</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Kacmaz</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Selcuk</surname>
<given-names>MT</given-names>
</name>
<etal/>
</person-group>. <article-title>Relationship of admission haematological indices with infarct-related artery patency in patients with acute ST-segment elevation myocardial infarction treated with primary angioplasty</article-title>. <source>Coron Artery Dis</source>. <year>2007</year>;<volume>18</volume>(<issue>8</issue>):<fpage>639</fpage>–<lpage>644</lpage>.</citation>
</ref>
<ref id="bibr16-0003319711436247">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kamath</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Blann</surname>
<given-names>AD</given-names>
</name>
<name>
<surname>Lip</surname>
<given-names>GY</given-names>
</name>
</person-group>. <article-title>Platelet activation: assessment and quantification</article-title>. <source>Eur Heart J</source>. <year>2001</year>;<volume>22</volume>(<issue>17</issue>):<fpage>1561</fpage>–<lpage>1571</lpage>.</citation>
</ref>
<ref id="bibr17-0003319711436247">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gawaz</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Langer</surname>
<given-names>H</given-names>
</name>
<name>
<surname>May</surname>
<given-names>AE</given-names>
</name>
</person-group>. <article-title>Platelets in inflammation and atherogenesis</article-title>. <source>J Clin Invest</source>. <year>2005</year>;<volume>115</volume>(<issue>12</issue>):<fpage>3378</fpage>–<lpage>3384</lpage>.</citation>
</ref>
<ref id="bibr18-0003319711436247">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gasparyan</surname>
<given-names>AY</given-names>
</name>
<name>
<surname>Ayvazyan</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Mikhailidis</surname>
<given-names>DP</given-names>
</name>
<name>
<surname>Kitas</surname>
<given-names>GD</given-names>
</name>
</person-group>. <article-title>Mean platelet volume: a link between thrombosis and inflammation?</article-title> <source>Curr Pharm Des</source>. <year>2011</year>;<volume>17</volume>(<issue>1</issue>):<fpage>47</fpage>–<lpage>58</lpage>.</citation>
</ref>
<ref id="bibr19-0003319711436247">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pitsilos</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hunt</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Mohler</surname>
<given-names>ER</given-names>
</name>
<etal/>
</person-group>. <article-title>Platelet factor 4 localization in carotid atherosclerotic plaques: correlation with clinical parameters</article-title>. <source>Thromb Haemost</source>. <year>2003</year>;<volume>90</volume>(<issue>6</issue>):<fpage>1112</fpage>–<lpage>1120</lpage>.</citation>
</ref>
<ref id="bibr20-0003319711436247">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Luca</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Santagostino</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Secco</surname>
<given-names>GG</given-names>
</name>
<etal/>
</person-group>. <article-title>Mean platelet volume and the extent of coronary artery disease: results from a large prospective study</article-title>. <source>Atherosclresosis</source>. <year>2009</year>;<volume>206</volume>(<issue>1</issue>):<fpage>292</fpage>–<lpage>297</lpage>.</citation>
</ref>
<ref id="bibr21-0003319711436247">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tavil</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Sen</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Yazici</surname>
<given-names>HU</given-names>
</name>
<name>
<surname>Hizal</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Abaci</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Cengel</surname>
<given-names>A</given-names>
</name>
</person-group>. <article-title>Mean platelet volume in patients with metabolic syndrome and its relationship with coronary artery disease</article-title>. <source>Thromb Res</source>. <year>2007</year>;<volume>120</volume>(<issue>2</issue>):<fpage>245</fpage>–<lpage>250</lpage>.</citation>
</ref>
<ref id="bibr22-0003319711436247">
<label>22</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ihara</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kawamoto</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Matsumoto</surname>
<given-names>K</given-names>
</name>
<etal/>
</person-group>. <article-title>Relationship between platelet indexes and coronary angiographic findings in patients with ischemic heart disease</article-title>. <source>Pathophysiol Haemost Thromb</source>. <year>2006</year>;<volume>35</volume>(<issue>5</issue>):<fpage>376</fpage>–<lpage>379</lpage>.</citation>
</ref>
<ref id="bibr23-0003319711436247">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brown</surname>
<given-names>AS</given-names>
</name>
<name>
<surname>Hong</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>de Belder</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Megakaryocyte ploidy and platelet changes in human diabetes and atherosclerosis</article-title>. <source>Arterioscler Thromb Vasc Biol</source>. <year>1997</year>;<volume>17</volume>(<issue>4</issue>):<fpage>802</fpage>–<lpage>807</lpage>.</citation>
</ref>
<ref id="bibr24-0003319711436247">
<label>24</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nena</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Papanas</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Steiropoulos</surname>
<given-names>P</given-names>
</name>
<etal/>
</person-group>. <article-title> Mean platelet volume and platelet distribution width in non-diabetic subjects with obstructive sleep apnoea syndrome: new indices of severity? <italic>Platelets</italic></article-title>. <year>2011</year> Nov 10. [Epub ahead of print] doi: 10.3109/09537104.2011.632031.</citation>
</ref>
<ref id="bibr25-0003319711436247">
<label>25</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Papanas</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Symeonidis</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Maltezos</surname>
<given-names>E</given-names>
</name>
<etal/>
</person-group>. <article-title>Mean platelet volume in patients with type 2 diabetes mellitus</article-title>. <source>Platelets</source>. <year>2004</year>;<volume>15</volume>(<issue>8</issue>):<fpage>475</fpage>–<lpage>478</lpage>.</citation>
</ref>
<ref id="bibr26-0003319711436247">
<label>26</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Coban</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Ozdogan</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Yazicioglu</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Akcit</surname>
<given-names>F</given-names>
</name>
</person-group>. <article-title>The mean platelet volume in patients with obesity</article-title>. <source>Int J Clin Pract</source>. <year>2005</year>;<volume>59</volume>(<issue>8</issue>):<fpage>981</fpage>–<lpage>982</lpage>.</citation>
</ref>
<ref id="bibr27-0003319711436247">
<label>27</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Inanc</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Kaya</surname>
<given-names>MG</given-names>
</name>
<name>
<surname>Yarlioglues</surname>
<given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>The mean platelet volume in patients with non-dipper hypertension compared to dippers and normotensives</article-title>. <source>Blood Press</source>. <year>2010</year>;<volume>19</volume>(<issue>2</issue>):<fpage>81</fpage>–<lpage>85</lpage>.</citation>
</ref>
<ref id="bibr28-0003319711436247">
<label>28</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pathansali</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Bath</surname>
<given-names>P</given-names>
</name>
</person-group>. <article-title>Altered megakaryocyte-platelet haemostatic axis in hypercholesterolaemia</article-title>. <source>Platelets</source>. <year>2001</year>;<volume>12</volume>(<issue>5</issue>):<fpage>292</fpage>–<lpage>297</lpage>.</citation>
</ref>
<ref id="bibr29-0003319711436247">
<label>29</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Haubelt</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Simon</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Anders</surname>
<given-names>Ch</given-names>
</name>
<name>
<surname>Hellstern</surname>
<given-names>P</given-names>
</name>
</person-group>. <article-title>Platelet function tests for monitoring of acetylsalicylic acid: clinical significance in antiplatelet treatment</article-title>. <source>Hamostaseologie</source>. <year>2004</year>;<volume>24</volume>(<issue>3</issue>):<fpage>196</fpage>–<lpage>202</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>